SCHEDULE 13G/A: Venrock Healthcare Capital Partners Group Discloses 4.1% Stake in Applied Therapeutics
Schedule 13G Amendment
A group of Venrock Healthcare Capital Partners entities and individuals have filed an amended Schedule 13G, disclosing a collective beneficial ownership of 4.1% in Applied Therapeutics, Inc.'s common stock as of March 31, 2025.
Summary
- The filing is an Amendment No. 4 to Schedule 13G for Applied Therapeutics, Inc. (Issuer).
- The reporting group consists of Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Y Koh.
- As of March 31, 2025, the reporting persons collectively beneficially own 5,567,709 shares of Applied Therapeutics, Inc. Common Stock.
- This aggregate ownership represents 4.1% of the Issuer's outstanding Common Stock.
- The percentage is calculated based on 137,228,741 shares of Common Stock outstanding as of December 31, 2024, as reported in the Issuer's Annual Report on Form 10-K filed on April 15, 2024.
- All 5,567,709 shares are held with shared voting power and shared dispositive power among the reporting persons.
- The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment as it does not contain performance or forward-looking statements.
Future Outlook
NA
Industry Context
This Schedule 13G filing is a routine disclosure by an institutional investor group, Venrock Healthcare Capital Partners, regarding their passive ownership stake in Applied Therapeutics, Inc. Such filings are common in the investment industry, providing transparency on significant ownership positions in publicly traded companies.
Stakeholder Impact
- Shareholders are informed of the beneficial ownership stake held by the Venrock Healthcare Capital Partners group, providing transparency regarding significant investors in the company.
Key Dates
| Date | Description |
|---|---|
| 05/08/2023 | Date of previous Schedule 13G filing referenced for Power of Attorney exhibits. |
| 04/15/2024 | Date Applied Therapeutics, Inc. filed its Annual Report on Form 10-K, which reported shares outstanding. |
| 12/31/2024 | Date as of which 137,228,741 shares of Common Stock were reported outstanding by the Issuer. |
| 03/31/2025 | Date of event which requires the filing of this Schedule 13G statement. |
| 05/15/2025 | Date of filing of this Schedule 13G Amendment No. 4. |
Keywords
Applied Therapeutics, Venrock Healthcare Capital Partners, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.